Discontinued — last reported Q4 '17
Non-Current Assets
Intangibles (Net)
AbbVie Intangibles (Net) increased by 896.8% to $52.64B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 12.4%, from $60.07B to $52.64B. Over 5 years (FY 2020 to FY 2025), Intangibles (Net) shows a downward trend with a -8.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
CategoryMarket Position
SignalContext dependent
VolatilityModerate
First reportedQ3 2015
Last reportedQ4 2017
How to read this metric
High levels reflect significant investment in growth through acquisitions; changes indicate the impact of amortization or impairment charges.
Detailed definition
This includes the value of acquired intellectual property, such as patents, trademarks, and drug licenses, net of accumu...
Peer comparison
Very high in the pharmaceutical industry due to the reliance on patent-protected drug portfolios.
Metric ID:
intangible_assets_netHistorical Data
19 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.55B | $1.45B | $75.95B | $670.00M | $670.00M | $670.00M | $67.44B | $289.00M | $293.00M | $285.00M | $55.61B | $1.58B | $1.58B | $9.70B | $60.07B | $5.29B | $5.29B | $5.28B | $52.64B |
| QoQ Change | — | -6.5% | >999% | -99.1% | +0.0% | +0.0% | >999% | -99.6% | +1.4% | -2.7% | >999% | -97.2% | +0.0% | +513.6% | +519.6% | -91.2% | -0.1% | -0.1% | +896.8% |
| YoY Change | — | — | — | — | -56.8% | -53.8% | -11.2% | -56.9% | -56.3% | -57.5% | -17.5% | +446.7% | +439.2% | >999% | +8.0% | +234.9% | +234.6% | -45.5% | -12.4% |
Range$285.00M – $75.95B
CAGR+118.9%
Avg YoY Growth+286.5%
Median YoY Growth-12.4%
Intangibles (Net) at Other Companies
Frequently Asked Questions
- What is AbbVie's intangibles (net)?
- AbbVie (ABBV) reported intangibles (net) of $52.64B in Q4 2025.
- How has AbbVie's intangibles (net) changed year-over-year?
- AbbVie's intangibles (net) decreased by 12.4% year-over-year, from $60.07B to $52.64B.
- What is the long-term trend for AbbVie's intangibles (net)?
- Over 5 years (2020 to 2025), AbbVie's intangibles (net) has grown at a -8.7% compound annual growth rate (CAGR), from $82.88B to $52.64B.
- What does intangibles (net) mean?
- The value of non-physical assets like patents and brand names, minus their amortized cost.